RT @dmi_lincoln: Further study detailing use of TSPAN7 autoantibodies to characterise autoimmune diabetes in different populations. https:/…
Further study detailing use of TSPAN7 autoantibodies to characterise autoimmune diabetes in different populations.
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in ind…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in ind…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in ind…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in ind…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in ind…
#OpenAccess in @DiabetologiaJnl. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA https://t.co/qkYuaCWEtQ https://t.co/jGWX54B5GC
Tetraspanin 7 autoantibodies can predict progressive decline of beta cell function in individuals with #LADA: #type 1 diabetes, #islet antibodies 🔓https://t.co/bdOCIb2eFy https://t.co/VTH06cr6Kp